Seeing through the COVID-19 spin is a challenge even for those who have been writing and talking for years about the need to limit Big Pharma’s influence on health policy and law.

Perhaps the greatest change I have seen in vaccine regulation, policymaking and law over the past four decades has been the development of public-private business partnerships between Big Pharma and the government.

That seismic change has affected how new vaccines are developed, licensed and regulated and is influencing what we see happening today.

Since the coronavirus pandemic was declared by government officials in early 2020, lawmakers have been persuaded to build the entire global pandemic response around a single experimental biological product.

That single product is generating billions of dollars in profits for liability free drug companies and their partners.

The COVID-19 spin is reaching dizzying new heights every day, with fundamental facts about the experimental product’s risks and failures getting lost in the hard sell.

Government health officials have said that COVID-19 vaccines will be approved for use in children of any age by early 2022.

With the majority of adults suffering very strong COVID vaccine reactions, especially younger adults, why are there plans to give the messenger RNA cell disrupter biological to infants and young children when the CDC says the majority of children with COVID-19 disease either have mild symptoms or no symptoms at all?

The enormous sums of money that Big Pharma and government is spending on television and digital ad campaigns to make sure that every child and adult in America gets a COVID-19 vaccine is creating false impressions and assumptions.

When public policy precedes the science and aggressive advertising campaign blur the lines between facts and myths, truth gets lost in the spin and nobody is safe.